Surgery Versus Radiotherapy for Early Oropharyngeal Tumors: a Never-Ending Debate

Current Treatment Options in Oncology

Volumn 16, Issue 9, 2015, Pages

  Monnier, Yan ^a   Simon, Christian ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Early stage; Oropharyngeal cancer; Radiotherapy; Review; Trans oral surgery

Indexed keywords

BONE NECROSIS; BRAIN ISCHEMIA; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPARATIVE EFFECTIVENESS; DISEASE FREE SURVIVAL; EARLY CANCER; EXTERNAL BEAM RADIOTHERAPY; FUNCTIONAL ASSESSMENT; HIGH RISK PATIENT; HUMAN; IMAGE GUIDED ADAPTIVE RADIOTHERAPY; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; NECK DISSECTION; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION; RADIATION INJURY; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; TRANSORAL LASER MICROSURGERY; TRANSORAL ROBOTIC SURGERY; TRANSORAL SURGERY; TREATMENT INDICATION; TREATMENT OUTCOME; TRISMUS; XEROSTOMIA; ADJUVANT RADIOTHERAPY; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; LOW LEVEL LASER THERAPY; MICROSURGERY; MORTALITY; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; PRACTICE GUIDELINE; PROGNOSIS; RETROSPECTIVE STUDY; ROBOTIC SURGICAL PROCEDURE; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; HUMANS; LASER THERAPY; MICROSURGERY; NECK DISSECTION; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; ROBOTIC SURGICAL PROCEDURES; SURVIVAL RATE;

EID: 84937898815     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-015-0362-4     Document Type: Review

References (57)

1. Parkin DM et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.
2. Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Cancer Netw. 2011;9(6):665–73.
3. Mehanna H, Olaleye O, Licitra L. Oropharyngeal cancer—is it time to change management according to human papilloma virus status? Curr Opin Otolaryngol Head Neck Surg. 2012;20(2):120–4.
4. Parsons JT et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94(11):2967–80.
5. Hinni ML, Nagel T, Howard B. Oropharyngeal cancer treatment: the role of transoral surgery. Curr Opin Otolaryngol Head Neck Surg. 2015;23(2):132–8.
6. Rennemo E, Zatterstrom U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope. 2008;118(8):1350–6.
7. Ho AS et al. Decision making in the management of recurrent head and neck cancer. Head Neck. 2014;36(1):144–51.
8. Morris LG et al. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2011;29(6):739–46.
9. Peck BW et al. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck. 2013;35(6):794–9.
10. Hinni ML, Zarka MA, Hoxworth JM. Margin mapping in transoral surgery for head and neck cancer. Laryngoscope. 2013;123(5):1190–8. This is an article reporting on the average size of surgical margins and the oncologic outcomes obtained with TLM and margin mapping techniques.
11. Cohen MA et al. Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck. 2011;33(4):573–80.
12. Grant DG et al. Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery. Arch Otolaryngol Head Neck Surg. 2009;135(12):1225–30.
13. Haughey BH et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011;33(12):1683–94.
14. Haughey BH, Sinha P. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope. 2012;122 Suppl 2:S13–33.
15. Quon H. Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes. Laryngoscope. 2013;123(3):635–40. This is a review reporting on the oncologic outcomes between HPV-positive and HPV-negative OPSCC treated with TORS.
16. Chen MM et al. Transoral robotic surgery: a population-level analysis. Otolaryngol Head Neck Surg. 2014;150(6):968–75.
17. de Almeida JR et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope. 2014;124(9):2096–102.
18. Kelly K et al. Oncologic, functional and surgical outcomes of primary transoral robotic surgery for early squamous cell cancer of the oropharynx: a systematic review. Oral Oncol. 2014;50(8):696–703.
19. Morisod, B. and C. Simon, A meta-analysis on survival of patients treated with trans-oral surgery (TOS) versus radiotherapy (RT) for early stage squamous cell carcinoma of the oropharynx (OPSCC). Head Neck, 2014. doi:10.1002/hed.23995. This is a recent meta-analysis specifically addressing the question of oncologic outcomes in early stages OPSCC. The data show equivalent efficacy of both treatment modalities in terms of disease control.
20. Williams CE et al. Transoral laser resection versus lip-split mandibulotomy in the management of oropharyngeal squamous cell carcinoma (OPSCC): a case match study. Eur Arch Otorhinolaryngol. 2014;271(2):367–72. This is a retrospective study addressing the functional outcomes, rates of complications and cost of TOS approaches, as compared to traditional open surgical treatments of OPSCC.
21. Chen AM et al. Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer. Head Neck. 2015;37(3):381–5. This is a case control study comparing functional outcomes between TOS approaches and definitive radiotherapy. It shows better recovery of function with TOS.
22. Genden EM et al. Transoral robotic resection and reconstruction for head and neck cancer. Laryngoscope. 2011;121(8):1668–74.
23. Grant DG et al. Carcinoma of the tongue base treated by transoral laser microsurgery, part one: Untreated tumors, a prospective analysis of oncologic and functional outcomes. Laryngoscope. 2006;116(12):2150–5.
24. Leonhardt FD et al. Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function. Head Neck. 2012;34(2):146–54.
25. More YI et al. Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers. JAMA Otolaryngol Head Neck Surg. 2013;139(1):43–8.
26. Sinclair CF et al. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2011;137(11):1112–6.
27. Hutcheson KA et al. Functional outcomes after TORS for oropharyngeal cancer: a systematic review. Eur Arch Otorhinolaryngol. 2015;272 (2):463–71. This is a recent meta-analysis specifically addressing the question of functional outcomes in OPSCC treated with TORS. It shows overall good functional results and identifies baseline function, TNM stage, primary tumor location in the base of tongue and adjuvant chemo radiation therapy as predictors of poor functional prognosis.
28. Nichols AC et al. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)—study protocol for a randomized phase II trial. BMC Cancer. 2013;13:133.
29. Diaz-Molina JP et al. Functional and oncological results of non-surgical vs surgical treatment in squamous cell carcinomas of the oropharynx. Acta Otorrinolaringol Esp. 2012;63(5):348–54.
30. de Almeida, J.R, et al. Transoral robotic surgery is cost-effective compared to (Chemo)radiotherapy for early t-classification oropharyngeal carcinoma: A cost-utility analysis. Head Neck, 2014. doi:10.1002/hed.23930.
31. Dombree M et al. Cost comparison of open approach, transoral laser microsurgery and transoral robotic surgery for partial and total laryngectomies. Eur Arch Otorhinolaryngol. 2014;271(10):2825–34.
32. Dziegielewski PT et al. The mandibulotomy: friend or foe? Safety outcomes and literature review. Laryngoscope. 2009;119(12):2369–75.
33. Zafereo ME et al. Complications and functional outcomes following complex oropharyngeal reconstruction. Head Neck. 2010;32(8):1003–11.
34. Tsue TT et al. Comparison of cost and function in reconstruction of the posterior oral cavity and oropharynx. Free vs pedicled soft tissue transfer. Arch Otolaryngol Head Neck Surg. 1997;123(7):731–7.
35. Seikaly H et al. Functional outcomes after primary oropharyngeal cancer resection and reconstruction with the radial forearm free flap. Laryngoscope. 2003;113(5):897–904.
36. Lee SY et al. Comparison of oncologic and functional outcomes after transoral robotic lateral oropharyngectomy versus conventional surgery for T1 to T3 tonsillar cancer. Head Neck. 2014;36(8):1138–45. This is a prospective study reporting on the functional and oncologic outcomes between TORS, conventional TOS approaches and open surgery in the management of OPSCC.It shows better rates of negative margins with TORS and better functional as well as faster recovery times with TOS techniques as compared with open approaches.
37. Candela FC, Kothari K, Shah JP. Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck. 1990;12(3):197–203.
38. Lim YC et al. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck. Laryngoscope. 2006;116(7):1148–52.
39. Kuntz AL, Weymuller Jr EA. Impact of neck dissection on quality of life. Laryngoscope. 1999;109(8):1334–8.
40. Terrell JE et al. Pain, quality of life, and spinal accessory nerve status after neck dissection. Laryngoscope. 2000;110(4):620–6.
41. O'Brien CJ, Nettle WJ, Lee KK. Changing trends in the management of carcinoma of the oral cavity and oropharynx. Aust N Z J Surg. 1993;63(4):270–4.
42. Brown JS et al. Functional outcome in soft palate reconstruction using a radial forearm free flap in conjunction with a superiorly based pharyngeal flap. Head Neck. 1997;19(6):524–34.
43. Lee N et al. Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck. 2007;29(4):387–400.
44. Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: a review of the clinical experience to date. Int J Radiat Oncol Biol Phys. 2014;89(2):292–302.
45. Braam PM et al. Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62(3):659–64.
46. Deasy JO et al. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S58–63.
47. Gupta T et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol. 2012;104(3):343–8.
48. Kam MK et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25(31):4873–9.
49. Nutting CM et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127–36.
50. Mendenhall WM. Mandibular osteoradionecrosis. J Clin Oncol. 2004;22(24):4867–8.
51. Monnier Y et al. Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: incidence and risk factors. Otolaryngol Head Neck Surg. 2011;144(5):726–32.
52. Peterson DE et al. Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies. Support Care Cancer. 2010;18(8):1089–98.
53. Wetzels JW et al. Maximum mouth opening and trismus in 143 patients treated for oral cancer: a 1-year prospective study. Head Neck. 2014;36(12):1754–62.
54. Bensadoun RJ et al. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer. 2010;18(8):1033–8.
55. Chao KS et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys. 2004;59(1):43–50.
56. Scott AS, Parr LA, Johnstone PA. Risk of cerebrovascular events after neck and supraclavicular radiotherapy: a systematic review. Radiother Oncol. 2009;90(2):163–5.
57. Dorresteijn LD et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002;20(1):282–8.